The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding

Alzheimer's and Dementia

Volumn 11, Issue 7, 2015, Pages 823-831

  Beckett, Laurel A ^a   Donohue, Michael C ^b   Wang, Cathy ^a   Aisen, Paul ^c   Harvey, Danielle J ^a   Saito, Naomi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid cascade hypothesis; Subjective memory complaints

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; AGE; BRAIN; COGNITIVE DYSFUNCTION; COMPLICATION; DISEASE COURSE; LONGITUDINAL STUDY; MEMORY DISORDERS; MENTAL HEALTH; METABOLISM; MULTICENTER STUDY (TOPIC); PATHOLOGY; PROCEDURES;

AGE FACTORS; ALZHEIMER DISEASE; AMYLOID; BRAIN; COGNITIVE DYSFUNCTION; DISEASE PROGRESSION; HUMANS; LONGITUDINAL STUDIES; MEMORY DISORDERS; MENTAL STATUS SCHEDULE; MULTICENTER STUDIES AS TOPIC; NEUROIMAGING;

EID: 84937549048     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.05.004     Document Type: Review

References (28)

1. The Alzheimer's Association 2015 Alzheimer's disease facts and figures Alzheimers Dement 11 2015 332 384
2. J.L. Cummings, T. Morstorf, and K. Zhong Alzheimer's disease drug development pipeline: few candidates, frequent failures Alzheimers Res Ther 6 2014 37
3. L.S. Schneider, F. Mangialasche, N. Andreasen, H. Feldman, E. Giacobini, R. Jones, and et al. Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014 J Intern Med 275 2014 251 283
4. S.T. DeKosky, M.C. Carrillo, C. Phelps, D. Knopman, R.C. Petersen, R. Frank, and et al. Revision of the criteria for Alzheimer's disease: a symposium Alzheimers Dement 7 2011 e1 e12
5. R.C. Petersen Mild cognitive impairment N Engl J Med 364 2011 2227 2234
6. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, A.M. Fagan, and et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
7. L.S. Schneider The potential and limits for clinical trials for early Alzheimer's disease and some recommendations J Nutr Health Aging 14 2010 295 298
8. M.W. Weiner, D.P. Veitch, P.S. Aisen, L.A. Beckett, N.J. Cairns, R.C. Green, and et al. The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception Alzheimers Dement 9 5 2013 e111 e194
9. S.G. Mueller, M.W. Weiner, L.J. Thal, R.C. Petersen, C.R. Jack, W. Jagust, and et al. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimers Dement 1 2005 55 66
10. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, D.J. Harvey, and et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
11. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
12. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414
13. R.C. Mohs, D. Knopman, R.C. Petersen, S.H. Ferris, C. Ernesto, M. Grundman, and et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study Alzheimer Dis Assoc Disord 11 Suppl 2 1997 S13 S21
14. A. Rey L'examen clinique en psychologie 1964 Presses universitaires de France Paris
15. M.C. Donohue, R.A. Sperling, D.P. Salmon, D.M. Rentz, R. Raman, R.G. Thomas Australian Imaging, Biomarkers, and Lifestyle Flagship Study of Ageing Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Cooperative Study The preclinical Alzheimer cognitive composite: measuring amyloid-related decline JAMA Neurol 71 2014 961 970
16. R.I. Pfeffer, T.T. Kurosaki, C.H. Harrah, J.M. Chance, and S. Filos Measurement of functional activities in older adults in the community J Gerontol 37 1982 323 329
17. A.M. Dale, B. Fischl, and M.I. Sereno Cortical surface-based analysis. I. Segmentation and surface reconstruction NeuroImage 9 1999 179 194
18. P.A. Freeborough, N.C. Fox, and R.I. Kitney Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans Comput Methods Programs Biomed 53 1997 15 25
19. C.R. Jack, M.A. Bernstein, N.C. Fox, P. Thompson, G. Alexander, D. Harvey, and et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods J Magn Reson Imaging 27 2008 685 691
20. L.M. Shaw, H. Vanderstichele, M. Knapik-Czajka, C.M. Clark, P.S. Aisen, R.C. Petersen, and et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects Ann Neurol 65 2009 403 413
21. S.M. Landau, M.A. Mintun, A.D. Joshi, R.A. Koeppe, R.C. Petersen, P.S. Aisen for the Alzheimer's Disease Neuroimaging Initiative Amyloid deposition, hypometabolism, and longitudinal cognitive decline Ann Neurol 72 2012 578 586
22. M.C. Donohue, H. Jacqmin-Gadda, M. Le Goff, R.G. Thomas, R. Raman, A.C. Gamst Alzheimer's Disease Neuroimaging Initiative Estimating long-term multivariate progression from short-term data Alzheimers Dement 10 2014 S400 S410
23. J. Nettiksimmons, D. Harvey, J. Brewer, O. Carmichael, C. DeCarli, C.R. Jack Jr., and et al. Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline Neurobiol Aging 31 2010 1419 1428
24. J. Nettiksimmons, C. DeCarli, S. Landau, L. Beckett Alzheimer's Disease Neuroimaging Initiative Biological heterogeneity in ADNI amnestic mild cognitive impairment Alzheimers Dement 10 2014 511 521
25. D.R. Cox Partial likelihood Biometrika 62 1975 269 276
26. C.R. Jack Jr., D.,S. Knopman, W.J. Jagust, L.M. Shaw, P.S. Aisen, M.W. Weiner, and et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet Neurol 9 2010 119 128
27. C.R. Jack Jr., D.S. Knopman, W.J. Jagust, R.C. Petersen, M.W. Weiner, P.S. Aisen, and et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol 12 2013 207 216
28. J. Nettiksimmons, L. Beckett, C. Schwarz, O. Carmichael, E. Fletcher, and C. DeCarli Subgroup of ADNI normal controls characterized by atrophy and cognitive decline associated with vascular damage Psychol Aging 28 2013 191 201